<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        123-325-04
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2004
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ULTRAZOLE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        LANSOPRAZOLE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        15
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Capsule
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        14
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        29.50
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="RIYADH PHARMA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            RIYADH PHARMA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 407]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            RIYADH PHARMA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            RIYADH PHARMA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A02BC03
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>1. What ULTRAZOLE is and what it is used for?</strong><br />The active ingredient in Ultrazole Capsules is lansoprazole, which is a proton pump inhibitor. Proton pump inhibitors reduce the amount of acid that your stomach makes.</p><p>Your doctor may prescribe Ultrazole for the following indications:<br />● Treatment of duodenal and stomach ulcer<br />● Treatment of inflammation in your oesophagus (reflux oesophagitis)<br />● Prevention of reflux oesophagitis<br />● Treatment of heartburn and acid regurgitation<br />● Treatment of infections caused by the bacteria Helicobacter pylori when given in combination with antibiotic therapy<br />● Treatment or prevention of duodenal or stomach ulcer in patients requiring continued NSAID treatment (NSAID treatment is used against pain or inflammation)<br />● Treatment of Zollinger-Ellison syndrome. Your doctor may have prescribed Ultrazole for another indication or with a dose different from that which is written in this information leaflet.<br /><strong>Please follow your doctor&rsquo;s instructions for taking your medicine.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>2. Before you take ULTRAZOLE</strong><br /><strong>Subacute cutaneous lupus erythematosus (SCLE)</strong><br />Proton pump inhibitors are associated with very frequent cases of SCLE. If lesions occur, especially in sun-exposed areas of the skin, and if accompanied by arthralgia, the patient should seek medical help promptly and the health care professional should consider stopping this medication. SCLE after previous treatment with a proton pump inhibitor may increase the risk of SCLE with other proton pump inhibitors.</p><p><strong>Do not take Ultrazole and tell your doctor:</strong><br />● if you are allergic to lansoprazole or any of the other ingredients of this medicine (listed in section 6)<br />● if you are taking a medicine containing the active substance atazanavir (used in the treatment of HIV).</p><p><strong>Warnings and precautions</strong><br />Talk to your doctor or pharmacist before taking Ultrazole Capsules.<br />● Please tell your doctor if you have serious liver disease. The doctor may have to adjust your dosage.<br />● Your doctor may perform or have performed an additional investigation called an endoscopy in order to diagnose your condition and/or exclude malignant disease.<br />● If diarrhoea occurs during the treatment with Ultrazole contact your doctor immediately, as Ultrazole has been associated with a small increase in infectious diarrhoea.<br />● If your doctor has given you Ultrazole Capsules in addition to other medicines intended for the treatment of Helicobacter pylori infection (antibiotics) or together with anti-inflammatory medicines to treat your pain or rheumatic disease: please also read the package leaflets of these medicines carefully.<br />● Taking a proton pump inhibitor like Ultrazole, especially over a period of more than one year, may slightly increase your risk of fracture in the hip, wrist or spine. Tell your doctor if you have osteoporosis or if you are taking corticosteroids (which can increase the risk of osteoporosis). If you take Ultrazole Capsules<br />on a long-term basis (longer than 1 year) your doctor will probably keep you under regular surveillance.<br />● You should report any new and exceptional symptoms and circumstances whenever you see your doctor.<br />● Talk to your doctor before taking Ultrazole Capsules if you have ever had a skin reaction after treatment with a medicine similar to Ultrazole Capsules that reduces stomach acid.<br />● If you get a rash on your skin, especially in areas exposed to the sun tell your doctor as soon as you can, as you may need to stop your treatment with Ultrazole Capsules.<br />● Remember to also mention any other ill-effects like pain in your joints.<br />● Tell your doctor before taking this medicine, if you are due to have a specific blood test (Chromogranin A).</p><p>If you are not sure if any of the above applies to you, talk to your doctor or pharmacist before taking Ultrazole.</p><p><strong>Children</strong><br />Ultrazole Capsules should not be given to children.</p><p><strong>Other medicines and Ultrazole Capsules</strong><br />Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.<br />In particular tell your doctor if you are taking medicines containing any of the following active substances as Ultrazole may affect the way these drugs work:<br />● atazanavir (used in treatment of HIV) (see &lsquo;Do not take Ultrazole&rsquo;)<br />● ketoconazole, itraconazole, rifampicin (used to treat infections)<br />● digoxin (used to treat heart problems)<br />● theophylline (used to treat asthma)<br />● tacrolimus (used to prevent transplant rejection)<br />● fluvoxamine (used to treat depression and other psychiatric diseases)<br />● antacids (used to treat heartburn or acid regurgitation)<br />● sucralfate (used for healing ulcers)<br />● St John&acute;s wort (Hypericum perforatum) (used to treat mild depression) If you are not sure, talk to your doctor or pharmacist before taking Ultrazole.</p><p><strong>Taking Ultrazole with food and drink</strong><br />You should take Ultrazole at least 30 minutes before food.</p><p><strong>Pregnancy and breast-feeding</strong><br />If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.<br />Use of Ultrazole Capsules is not recommended during pregnancy, as there is no adequate experience on the use of lansoprazole during pregnancy. There is insufficient experience with use of lansoprazole during breastfeeding. Based on the results of animal studies, it is thought that lansoprazole crosses into the breast milk. When making a decision as to whether breast-feeding or therapy with lansoprazole should be continued or discontinued, your treating physician will consider the benefits of breastfeeding for your child and the benefits of therapy with Ultrazole for you.</p><p><strong>Driving and using machines</strong><br />Side effects such as dizziness, vertigo, tiredness and visual disturbances sometimes occur in patients taking Ultrazole Capsules.<br />If you experience side effects like these you should take caution as your ability to react may be decreased. You alone are responsible to decide if you are in a fit condition to drive a motor vehicle or perform other tasks that demand increased concentration.<br />Because of their effects or undesirable effects, one of the factors that can reduce your ability to do these things safely is your use of medicines. Descriptions of these effects can be found in other sections.</p><p>Read all the information in this leaflet for guidance. Discuss with your doctor or pharmacist if you are unsure about anything.</p><p><strong>Important Information<br />Ultrazole Capsules contain sucrose</strong><br />If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>3. How to take Ultrazole?</strong><br />Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><p><strong>Taking your medicine</strong><br />● Swallow the capsule whole with a glass of water. If you find the capsules difficult to swallow your doctor may advise on alternative ways to take your medicine. Do not crush or chew these capsules or the content of an emptied capsule because this will stop them from working properly.<br />● For the best results from your medicine you should take Ultrazole Capsules at least 30 minutes before food. If you are taking Ultrazole Capsules once a day, try to take it at the same time each day.<br />● You may get best results if you take Ultrazole first thing in the morning. If you are taking Ultrazole Capsules twice a day, you should have the first dose in the morning and the second dose in the evening.<br />● The dose of Ultrazole Capsules depends on your condition. The recommended doses of Ultrazole Capsules for adults are given below. Your doctor will sometimes prescribe you a different dose and will tell you how long your treatment will last.</p><p>The usual doses for adults are:<br /><strong>Treatment of heartburn and acid regurgitation:</strong><br />one 15mg or 30mg capsule for 4 weeks. If symptoms persist you should report to yourdoctor. If your symptoms are not relieved within 4 weeks, please contact your doctor.</p><p><strong>Treatment of duodenal ulcer:</strong><br />one 30mg capsule every day for 2 weeks</p><p><strong>Treatment of stomach ulcer:</strong><br />one 30mg capsule every day for 4 weeks</p><p><strong>Treatment of inflammation in your oesophagus (reflux oesophagitis):</strong><br />one 30mg capsule every day for 4 weeks</p><p><strong>Long-term prevention of reflux oesophagitis:</strong><br />one 15mg capsule every day, your doctor may adjust your dose to one 30mg capsule everyday.</p><p><strong>Treatment of infection of Helicobacter pylori:</strong><br />The recommended dose is one 30mg capsule in combination with two different antibiotics in the morning and one 30mg capsule in combination with two different antibiotics in the evening.</p><p>Treatment will usually be every day for 7 days.<br />The recommended combinations of antibiotics are:</p><ul><li>30mg Ultrazole together with 250-500mg clarithromycin and 1000mg amoxicillin</li><li>30mg Ultrazole together with 250mg clarithromycin and 400- 500mg metronidazol.</li></ul><p>If you are being treated for infection because you have an ulcer, it is unlikely that your ulcer will return if the infection is successfully treated. To give your medicine the best chance of working, take it at the right time and do not miss a dose.</p><p><strong>Treatment of duodenal or stomach ulcer in patients requiring continued NSAID treatment:</strong><br />one 30mg capsule every day for 4 weeks.</p><p><strong>Prevention of duodenal or stomach ulcer in patients requiring continued NSAID treatment:</strong><br />one 15mg capsule every day, your doctor may adjust your dose to one 30mg capsule every day.</p><p><strong>Zollinger-Ellison syndrome:</strong><br />The recommended dose is two 30mg capsules every day to start with, then depending on how you respond to Ultrazole Capsules the dose that your doctor decides is best for you.</p><p><strong>Use in children</strong><br />Ultrazole Capsules should not be given to children.</p><p><strong>If you take more Ultrazole than you should</strong><br />Tell your doctor or go to your nearest hospital straight away. Remember to take with you any Ultrazole capsules that are left and the pack.<br />This is so the doctor knows what you have taken.</p><p><strong>If you forget to take Ultrazole</strong><br />If you forget to take a dose, take it as soon as you remember, unless it is time for your next dose. Do not take a double dose to make up for a forgotten dose.</p><p><strong>Stopping treatment</strong><br />Do not stop treatment early because your symptoms have got better. Your condition may not have been fully healed and may reoccur if you do not finish your course of treatment.<br /><strong>If you have any further questions on the use of this medicine, ask your doctor, pharmacist.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>4. Possible side effects</strong><br />Like all medicines, Ultrazole can cause side effects, although not everybody gets them.</p><p><strong>The following side effects are common (may affect up to 1 in 10 people):</strong><br />● headache, dizziness<br />● diarrhoea, constipation, stomach pains, feeling or being sick, wind, dry or sore mouth or throat<br />● skin rash, itching<br />● changes in liver function test values<br />● tiredness.<br /><strong>The following side effects are uncommon (may affect up to 1 in 100 people):</strong><br />● depression<br />● joint or muscle pain<br />● fluid retention or swelling<br />● changes in blood cell counts<br />● fracture of the hip, wrist or spine<br /><strong>The following side effects are rare (may affect up to 1 in 1,000 people):</strong><br />● fever<br />● restlessness, drowsiness, confusion, hallucinations, insomnia, visual disturbances, vertigo<br />● a change in the way things taste, loss of appetite, inflammation of your tongue (glossitis)<br />● skin reactions such as burning or pricking feeling under the skin, bruising, reddening and excessive sweating<br />● sensitivity to light<br />● hair loss<br />● feelings of ants creeping over the skin (paresthesiae), trembling<br />● anaemia (paleness)<br />● kidney problems<br />● pancreatitis<br />● inflammation of the liver (may be seen as yellow skin or eyes)<br />● breast swelling in males, impotence<br />● candidiasis (fungal infection, may affect skin or the mucosa)<br />● angioedema; You should see your doctor immediately if you experience symptoms of angioedema, such as swollen face, tongue or pharynx, difficulty to swallow, hives and difficulties to breath.<br /><strong>The following side effects are very rare (may affect up to 1 in 10,000 people):</strong><br />● severe hypersensitivity reactions including shock. Symptoms of a hypersensitivity reaction may include fever, rash, swelling and sometimes a fall in blood pressure<br />● inflammation of your mouth (stomatitis)<br />● colitis (bowel inflammation)<br />● changes in test values such as sodium, cholesterol and triglyceride levels<br />● very severe skin reactions with reddening, blistering, severe inflammation and skin loss. (Stevens-Johnson syndrome, toxic epidermal necrolysis)<br />● very rarely Lansoprazole may cause a reduction in the number of white blood cells and your resistance to infection may be decreased. If you experience an infection with symptoms such as fever and serious deterioration of your general condition, or fever with local infection symptoms such as sore throat/pharynx/mouth or urinary problems you should see your doctor immediately. A blood test will be taken to check possible reduction of white blood cells (agranulocytosis).</p><p><strong>Frequency not known (frequency cannot be estimated from the available data):</strong></p><ul><li>If you are on Lansoprazole for more than three months it is possible that the levels of magnesium in your blood may fall. Low levels of magnesium can be seen as fatigue, involuntary muscle contractions, disorentation, convulsions, dizziness, increased heart rate. If you get any of these symptoms, please tell your doctor promptly. Low levels of magnesium can also lead to a reduction in potassium or calcium levels in the blood. Your doctor may decide to perform regular blood tests to monitor your levels of magnesium.</li><li>rash, possibly with pain in the joints.</li></ul><p><strong>If any of the side effects gets serious, or if you notice any side effects not listed in the leaflet, please tell your doctor or pharmacist</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>5. How to store Ultrazole?</strong><br />&ndash; Keep out of reach and sight of children.<br />&ndash; Store below 30&deg;C.<br />&ndash; Store in the original package in order to protect from light and moisture.<br />&ndash; Do not use Ultrazole after the expiry date which is stated on the jar or the package.<br />&ndash; Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Ultrazole contains?</strong><br />Each capsule contains lansoprazole 15 mg or 30 mg (Pellets 8.5%) &amp; Capsule shell.</p><p><strong>Ultrazole 15mg capsules&nbsp;</strong>having light green opaque body and green opaque head with printing RP 28 in white on head, containing white to off white spherical enteric coated pellets.</p><p><strong>Ultrazole 30mg capsules&nbsp;</strong>having yellow opaque body and blue opaque head with printing RP 9 in white on head, containing white to off white spherical enteric coated pellets.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Ultrazole 15mg: 28 capsules in a white high density polyethylene bottle with child resistant plastic cap with desiccant.
Ultrazole 30mg: 14 capsules in a white high density polyethylene bottle with child resistant plastic cap with desiccant.
Hospital packs: contain Ultrazol capsules 15 mg or 30 mg
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorisation Holder and M a n u f a c t u r e r</strong><br />Medical and Cosmetic Products Company Ltd.<br />(Riyadh Pharma)<br />P.O.Box 442, Riyadh 11411<br />Fax: +966 11 265 0505<br />Email: contact@riyadhpharma.com<br />For any information about this medicinal product, please contact the local representative of marketing authorisation holder:<br />Saudi Arabia<br />Marketing department<br />Riyadh<br />Tel: +966 11 265 0111<br />Email: marketing@riyadhpharma.com</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in (05/2017)
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>المادة الفعالة في ألترازول هي لانسوبرازول ، وهي مثبطة لمضخة البروتون. مثبطات مضخة البروتون تقلل من كمية الأحماض التي تفرزها معدتك. قد يصف طبيبك ألترازول للحالات التالية:</p><p>علاج قرحة الاثني عشرو المعدة .</p><p>(علاج التهاب المريء (ارتجاع المريء .</p><p>الوقاية من ارتجاع المريء .</p><p>علاج حرقة المعدة وارتجاع الحمض .</p><p>علاج العدوى التي تسببها بكتيريا هيليكوباكتر بيلوري عندما تعطى مع المضادات الحيوية كعلاج مشترك.</p><p>للعلاج أو الوقاية من قرحة الاثني عشر أو المعدة في المرضى الذين يحتاجون إلى علاج &nbsp;مستمر بمضادات الالتهاب الغير ستيرويدية .</p><p>علاج متلازمة زولينجر إليسون . قد يكون طبيبك قد وصف لانسوبرازول &nbsp;لسبب أخر أو بجرعة مختلفة عن تلك المكتوبة في هذه النشرة. يرجى اتباع تعليمات الطبيب لتناول الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>قبل القيام بتناول ألترازول </strong></p><p><strong>(</strong><strong>SCLE</strong><strong>)الذئبة الحمامية الجلدية شبة الحادة </strong></p><p>SCLEترتبط مثبطات مضخة البروتون مع حالات متكررة جدا من.</p><p>في حالة حدوث إصابات، وخاصة في المناطق المعرضة للشمس من الجلد، وإذا رافقه ألم مفصلي، ينبغي على المريض طلب المساعدة الطبية فورا وعلى مقدم الرعاية الصحية المهنية أن يبحث وضع ايقاف هذا الدواء. SCLEحدوث</p><p>SCLEمع علاجات سابقة بمثبطات مضخة البروتون قد تزيد من خطر الإصابة بــ&nbsp;&nbsp;</p><p>مع غيرها من مثبطات مضخة البروتون</p><p><strong>&nbsp;</strong></p><p><strong>لا تتناول ألترازول وأخبر طبيبك إذا كنت:</strong></p><p>إذا كنت تعاني من حساسية تجاه لانسوبرازول أو أي من المكونات الأخرى لهذا الدواء (المدرجة في القسم (6</p><p>(إذا كنت تتناول دواء يحتوي على المادة الفعالة أتازانافير (المستخدمة في علاج فيروس نقص المناعة البشرية.</p><p>&nbsp;</p><p><strong>التحذيرات و الاحتياطات</strong></p><p>تحدث مع طبيبك أو الصيدلي قبل تناول ألترازول.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; یرجی إخبار طبیبك إذا کنت تعاني من أمراض کبدیة خطیرة. قد يحتاج الطبيب لضبط الجرعة الخاصة بك.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يحتاج طبيبك القيام بإجراء أو قام بإجراء إضافي يسمی التنظير من أجل تشخيص حالتك و / أو استبعاد الأمراض الخبيثة.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا حدث إسهال أثناء العلاج مع لانسوبرازول اتصل بطبیبك علی الفور، حیث أن ألترازول قد يرتبط بزیادة طفيفة في الإسهال المصحوب بعدوى.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا وصف لك طبيبك ألترازول &nbsp;كبسولات بالإضافة إلى أدوية أخرى مخصصة لعلاج عدوى هيليكوباكتر بيلوري ( المضادات الحيوية ) أو مع أدوية مضادة للالتهابات لمعالجة الألم أو مرض الروماتيزم: يرجى أيضا قراءة نشرات هذه الأدوية بعناية.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يؤدي تناول مثبط مضخة البروتون مثل ألترازول، وخاصة خلال فترة تزيد عن سنة واحدة، إلى زيادة خطر الإصابة بالكسور في الورك أو الرسغ أو العمود الفقري. أخبر طبيبك إذا كان لديك هشاشة العظام أو إذا كنت تتناول الستيرويدات القشرية (التي يمكن أن تزيد من خطر هشاشة العظام). إذا كنت تتناول كبسولات لانسوبرازول على أساس طويل الأجل (أطول من 1 سنة) طبيبك ربما يبقيك تحت المراقبة الاعتيادية.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب عليك الإبلاغ عن أي أعراض وظروف جديدة واستثنائية كلما راجعت &nbsp;طبيبك.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تحدث مع طبيبك قبل تناول كبسولات ألترازول إذا كان حدث لك في أي وقت مضى تحسس جلدي بعد العلاج بدواء مشابه لكبسولات ألترازول التي تقلل من حمض المعدة.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا حدث لك طفح جلدي ، وخاصة في المناطق المعرضة لأشعة الشمس أخبر طبيبك بأسرع ما يمكن، حيث أنه قد تحتاج إلى وقف العلاج بكبسولات ألترازول.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تذكر أن تخبر طبيبك أيضا بأي آثار سيئة أخرى مثل ألم المفاصل.</p><p>&middot;&nbsp; &nbsp; A&nbsp; &nbsp; &nbsp;أخبر طبيبك قبل تناول هذا الدواء، إذا كان من المقرر أن يكون لديك فحص دم معين (كروموغرانين .</p><p>إذا لم تكن متأكدا مما إذا كان أي مما سبق ينطبق عليك، تحدث مع طبيبك أو الصيدلي قبل تناول ألترازول.</p><p>&nbsp;</p><p><strong>الأطفال</strong></p><p>لا ينبغي إعطاء كبسولات ألترازول للأطفال.</p><p>&nbsp;</p><p><strong>كبسولات ألترازول و الأدوية الأخرى</strong></p><p>يرجى إخبار الطبيب أو الصيدلي إذا كنت تتناول أو تناولت في الآونة الأخيرة أي أدوية أخرى، بما في ذلك الأدوية التي تم الحصول عليها دون وصفة طبية.</p><p>&nbsp;</p><p>على وجه الخصوص أخبر طبيبك إذا كنت تتناول أدوية&nbsp; تحتوي على أي من المواد الفعالة التالية حيث أن ألترازول قد يؤثر على طريقة عمل هذه الأدوية:</p><p>&middot;&nbsp; &nbsp; &nbsp; &nbsp;(&nbsp; أتازانافير (المستخدم في علاج فيروس نقص المناعة البشرية) (انظر &#39;لا تتناول لانسوبرازول&#39;</p><p>&middot;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;(كيتوكونازول، إتراكونازول، ريفامبيسين (يستخدم لعلاج العدوى</p><p>&middot;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;(ديجوكسين (يستخدم لعلاج مشاكل القلب</p><p>&middot;&nbsp; &nbsp; &nbsp;(&nbsp; &nbsp; الثيوفيلين (يستخدم لعلاج الربو</p><p>&middot;&nbsp; &nbsp; &nbsp; (&nbsp; &nbsp;تاكروليموس (يستخدم لمنع رفض زرع الأعضاء</p><p>&middot;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;(فلوفوكسامين (يستخدم لعلاج الاكتئاب والأمراض النفسية الأخرى</p><p>&middot;&nbsp; &nbsp; &nbsp; &nbsp;(&nbsp; مضادات الحموضة (المستخدمة لعلاج حرقة المعدة أو ارتجاع الحمض</p><p>&middot;&nbsp; &nbsp;(&nbsp; &nbsp; &nbsp; سكرالفات (تستخدم لعلاج القرح&nbsp;</p><p>&middot;&nbsp; &nbsp; &nbsp; (&nbsp; &nbsp;نبتة سانت جونز (هيبيريكوم بيرفوراتوم) (تستخدم لعلاج الاكتئاب الخفي</p><p>إذا لم تكن متأكدا، تحدث مع طبيبك أو الصيدلي قبل تناول أولترازول.</p><p>&nbsp;</p><p><strong>تناول ألترازول مع الطعام والشراب</strong></p><p>يجب أن تتناول ألترازول قبل الطعام بـ 30 دقيقة على الأقل.</p><p><strong>الحمل والرضاعة الطبيعية</strong></p><p>إذا كنتي حاملا أو مرضعة، تعتقدين أنك قد تكوني حاملا أو تخططين لانجاب طفل، اطلبي من طبيبك أو الصيدلي تقديم المشورة قبل تناول هذا الدواء.</p><p>لا ينصح باستخدام ألترازول &nbsp;كبسولات خلال فترة الحمل، كما لا توجد خبرة كافية على استخدام لانسوبرازول خلال فترة الحمل.</p><p>لا توجد خبرة كافية على استخدام لانسوبرازول أثناء الرضاعة الطبيعية.</p><p>استنادا إلى نتائج الدراسات الحيوانية، يعتقد أن لانسوبرازول يعبر الى حليب الثدي.</p><p>عند اتخاذ قرار بشأن ما إذا كانت الرضاعة الطبيعية أو العلاج مع لانسوبرازول ينبغي أن يستمر أو يتوقف، الطبيب المعالج الخاص بك سوف ينظر في فوائد الرضاعة الطبيعية لطفلك وفوائد العلاج مع لانسوبرازول بالنسبة لك.</p><p>&nbsp;</p><p><strong>القيادة واستخدام </strong><strong>ال</strong><strong>آلات</strong></p><p>الآثار الجانبية مثل الدوخة والدوار والتعب والاضطرابات البصرية تحدث في بعض الأحيان في المرضى الذين يتناولون كبسولات لانسوبرازول.</p><p>إذا كنت تعاني من آثار جانبية مثل هذه يجب&nbsp; توخي الحذر حيث قد تنخفض قدرتك على رد الفعل. أنت وحدك مسؤول عن تقرير ما إذا كنت في حالة صالحة لقيادة السيارة أو أداء المهام الأخرى التي تتطلب زيادة التركيز.</p><p>بسبب&nbsp; الآثار غير المرغوبة، واحدة من العوامل التي يمكن أن تقلل من قدرتك على القيام بهذه الأمور بأمان هو استخدامك للأدوية. ويمكن الاطلاع على وصف هذه الآثار في أقسام أخرى.</p><p>اقرأ جميع المعلومات الواردة في هذه النشرة للحصول على الإرشادات. ناقش مع طبيبك أو الصيدلي إذا كنت غير متأكد من أي شيء.</p><p><strong>معلومات هامة<br />كبسولات ألترازول تحتوي على السكروز</strong><br />إذا أخبرك طبيبك بأنك تعاني من عدم تحمل بعض السكريات،<br />فاتصل بطبيبك قبل تناول هذا الدواء</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>دائما تناول هذا الدواء تماما كما قال لك الطبيب أو الصيدلي. تحقق مع طبيبك أو الصيدلي إذا كنت غير متأكد.</p><p><strong>تناول الدواء الخاص بك</strong></p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>ابتلع الكبسولة بأكملها مع كوب من الماء. إذا وجدت من الصعب ابتلاع الكبسولات&nbsp; الطبيب قد ينصح بطرق بديلة لتناول الدواء. لا تسحق أو تمضغ هذه الكبسولات أو محتوى الكبسولة&nbsp; لأن هذا سوف يمنعهم من العمل بشكل صحيح.</p><p>للحصول على أفضل النتائج من الدواء يجب أن تتناول كبسولات ألترازول قبل 30 دقيقة على الأقل من الطعام.</p><p><strong>&nbsp;&nbsp;</strong>إذا كنت تتناول كبسولات ألترازول مرة واحدة في اليوم، حاول&nbsp; أن تتناولها في نفس الوقت كل يوم. قد تحصل على أفضل النتائج إذا&nbsp; تناولت ألترازول أول شيء&nbsp; في الصباح. إذا كنت تتناول كبسولات ألترازول مرتين في اليوم، يجب أن تكون الجرعة الأولى في الصباح والجرعة الثانية في المساء.</p><p><strong>&nbsp;</strong>جرعة كبسولات ألترازول تعتمد على حالتك. الجرعات الموصى بها من كبسولات ألترازول للكبار كما يلي. سوف يصف لك طبيبك أحيانا جرعة مختلفة وسوف يخبرك بمدى استمرار العلاج.</p><p>الجرعات المعتادة للبالغين هي:</p><p><strong>علاج حرقة المعدة وارتجاع الحمض:</strong></p><p>كبسولة واحدة 15ملجم &nbsp;أو 30 ملجم &nbsp;لمدة 4 أسابيع. إذا استمرت الأعراض يجب عليك إبلاغ الطبيب. إذا لم يتم تخفيف الأعراض خلال 4 أسابيع، يرجى الاتصال بطبيبك.</p><p>&nbsp;</p><p><strong>قرحة الاثني عشر:</strong></p><p>كبسولة واحدة 30 ملجم كل يوم لمدة اسبوعين .</p><p>&nbsp;</p><p><strong>قرحة المعدة:</strong></p><p>كبسولة واحدة 30 ملجم كل يوم لمدة 4 أسابيع .</p><p>&nbsp;</p><p><strong>(علاج الالتهاب في المريء (ارتجاع المريء:</strong></p><p>كبسولة واحدة 30 ملجم &nbsp;كل يوم لمدة 4 أسابيع .</p><p>&nbsp;</p><p><strong>الوقاية على المدى الطويل من ارتجاع المريء</strong><strong>:</strong></p><p>كبسولة واحدة 15 ملجم &nbsp;كل يوم، طبيبك قد يضبط الجرعة الخاصة بك إلى كبسولة 30 ملجم واحدة كل يوم.</p><p>&nbsp;</p><p><strong>علاج عدوى بكتيريا هيليكوباكتر بيلوري: </strong></p><p>الجرعة المعتادة هي كبسولة واحدة 30 ملجم بالاقتران مع اثنين من المضادات الحيوية المختلفة في الصباح وكبسولة واحدة 30 ملجم بالاقتران مع اثنين من المضادات الحيوية المختلفة في المساء. والعلاج يكون عادة كل يوم لمدة 7 أيام.</p><p>التوليفات الموصى بها من المضادات الحيوية هي</p><p>30 ملجم&nbsp;</p><p>&nbsp; &nbsp; &nbsp;&nbsp;ألترازول جنبا إلى جنب مع 250-500 ملجم كلاريثروميسين و1000 ملجم أموكسيسيلين</p><p>&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 30 ملجم ألترازول جنبا إلى جنب مع 250 ملجم كلاريثروميسين و400-500 ملجم ميترونيدازول</p><p>إذا كنت تعالج العدوى لأن لديك قرحة، فإنه من غير المحتمل أن القرحة الخاصة بك ستعود إذا تم علاج العدوى بنجاح.</p><p>لإعطاء الدواء أفضل فرصة لعمل مفعول، تناوله في الوقت المحدد ولا تنسى جرعة ما.</p><p>&nbsp;</p><p><strong>علاج قرحة الاثني عشر أو قرحة المعدة في المرضى الذين يحتاجون إلى علاج مستمر بمضادات الالتهاب الغير ستيرويدية:</strong></p><p><strong>&nbsp;</strong>كبسولة واحدة 30 ملجم كل يوم لمدة 4 أسابيع.</p><p>&nbsp;</p><p><strong>الوقاية من قرحة الاثني عشر أو قرحة المعدة في المرضى الذين يحتاجون إلى علاج مستمر بمضادات الالتهاب الغير ستيرويدية: </strong></p><p>كبسولة واحدة 15 ملجم كل يوم، طبيبك قد يضبط الجرعة الخاصة بك إلى كبسولة واحدة 30 ملجم كل يوم.</p><p>&nbsp;</p><p><strong>متلازمة زولينجر إليسون:</strong></p><p>الجرعة الموصى بها&nbsp; 2 كبسولة 30 ملجم كل يوم كبداية. ثم سوف يقرر طبيبك الجرعة الأفضل لك اعتمادا على كيفية الاستجابة لألترازول</p><p><strong>المرضى الذين يعانون من مشاكل في الكبد</strong></p><p>إذا كان لديك مشاكل في الكبد الحاد طبيبك قد يبقي الجرعة على كبسولة واحدة في اليوم.</p><p><strong>الاستخدام في الأطفال</strong></p><p>لا يجب اعطاء ألترازول للأطفال.</p><p><strong>إذا تناولت المزيد من ألترازول أكثر مما يجب</strong></p><p>أخبر طبيبك أو اذهب إلى أقرب مستشفى لديك على الفور. تذكر أن تأخذ معك كبسولات ألترازول المتبقية والعبوة. هذا حتى يعرف الطبيب ماذا قد تناولت.</p><p><strong>إذا نسيت أن تتناول ألترازول</strong></p><p>إذا كنت قد نسيت أن تتناول جرعة، تناولها حالما تذكر، إلا إذا قد حان الوقت لتناول جرعة تالية. لا تتناول جرعة مضاعفة لتعويض الجرعة المنسية.</p><p><strong>إيقاف العلاج </strong></p><p>لا تتوقف عن تناول ألترازول فقط لأن الأعراض تحسنت. من المحتمل عدم شفائك تماما وقد تتكرر حالتك اذا لم تكمل العلاج .</p><p><strong>إذا كان لديك أي أسئلة أخرى حول استخدام هذا الدواء، اسأل طبيبك، الصيدلي.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية، يمكن أن يسبب ألترازول آثار جانبية، على الرغم من أن هذه الآثار لا تحدث لكل شخص.</p><p>&nbsp;</p><p><strong>الأعراض الجانبية التالية شائعة (تؤثر </strong><strong>على ما يصل إلى 1 من كل 10 أشخاص</strong><strong>)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصداع، والشعور بالدوار</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإسهال، والإمساك، وآلام في المعدة، والشعور بالإعياء (الغثيان) أو أن تكون مريضا بالفعل (القيء)والريح ،جفاف أو التهاب الفم أو الحلق</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي، والحكة</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>التغييرات في قيم اختبارات عمل الكبد</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>الإعياء.</p><p><strong>الأعراض الجانبية التالية غير شائعة (تؤثر </strong><strong>على ما يصل إلى </strong><strong>1 فى كل 100 شخص)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الاكتئاب</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آلام المفاصل أو العضلات</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احتباس الماء مما قد يسبب تورم الذراعين أو الأرجل</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كسر في عظام الحوض أو المعصم أو العمود الفقري.</p><p><strong>الأعراض الجانبية التالية نادرة (تؤثر </strong><strong>على ما يصل إلى </strong><strong>1 فى كل 1000 شخص)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحمى</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالتعب، والنعاس، والارتباك، والهلوسة، والأرق، واضطرابات بصرية، والدوار</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيير في طريقة طعم الأشياء، وفقدان الشهية، والتهاب لسانك (التهاب اللسان)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ردود فعل الجلد مثل الحرق أو الشعور بالوخز تحت الجلد، كدمات، احمرار والتعرق المفرط</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحساسية للضوء</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تساقط الشعر</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعور بالنمل الزاحف على الجلد (تنميل)، رجفة</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقر الدم (شحوب)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في الكلى</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب البنكرياس</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الكبد (يظهر على هيئة اصفرار في الجلد والعيون)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم الثدي في الذكور، والعجز الجنسي</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; داء الكانديدا (عدوى فطرية، قد تؤثر على الجلد أو الغشاء المخاطي)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وذمة وعائية. يجب أن ترى الطبيب فورا إذا واجهت أعراض الوذمة الوعائية، مثل تورم الوجه واللسان أو البلعوم، وصعوبة الابتلاع، البثور وصعوبات في التنفس.</p><p><strong>الأعراض الجانبية التالية نادرة جدا (تؤثر </strong><strong>على ما يصل إلى </strong><strong>1 فى كل 10،000 شخص)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فرط الحساسية الشديد &nbsp;بما في ذلك الصدمة. أعراض رد فعل فرط الحساسية قد تشمل الحمى والطفح الجلدي والتورم وأحيانا انخفاض في ضغط الدم</p><p>&middot;&nbsp; &nbsp; &nbsp;( التهاب فمك (التهاب الفم</p><p>&middot;&nbsp; &nbsp;(&nbsp; &nbsp;التهاب القولون (التهاب الأمعاء</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التغيرات في قيم الاختبارات مثل مستويات الصوديوم والكوليسترول والدهون الثلاثية</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ردود فعل الجلد الشديدة جدا مع احمرار، تلف، التهاب حاد وفقدان الجلد. (متلازمة ستيفنزجونسون، تقشر الانسجة المتموتة البشروية التسممي)</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>نادرا جدا قد يسبب لانسوبرازول انخفاضا في عدد خلايا الدم البيضاء وقد تنخفض مقاومتك للعدوى. إذا كنت تعاني من عدوى مع أعراض مثل الحمى وتدهور خطير في حالتك العامة، أو حمى مع أعراض عدوى موضعية مثل التهاب الحلق / البلعوم / الفم أو مشاكل في البول يجب أن ترى الطبيب على الفور. وسيتم إجراء فحص الدمللتحقق من الحد الممكن من خلايا الدم البيضاء (ندرة المحببات.<strong> </strong></p><p><strong>تكرارها غير معروف (لا يمكن تقدير تكرارها من البيانات المتاحة) </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تتناول ألترازول لأكثر من ثلاثة أشهر فمن الممكن أن مستويات المغنيسيوم في الدم قد تنخفض. ويمكن معرفة المستويات المنخفضة من المغنيسيوم &nbsp;في التعب، وتقلصات العضلات اللاإرادية، والارتباك، والتشنجات، والدوخة، وزيادة معدل ضربات القلب. إذا كان لديك أي من هذه الأعراض، من فضلك أخبر طبيبك فورا. المستويات المنخفضة من المغنيسيوم يمكن أن تؤدي أيضا إلى انخفاض فى البوتاسيوم أو الكالسيوم فى الدم. طبيبك قد يقرر إجراء اختبارات الدم العادية لرصد مستويات المغنيسيوم لديك.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي، ربما مع ألم في المفاصل.</p><p><strong>إذا أصبح أي من الآثار الجانبية خطيراً، أو إذا لاحظت أي آثار جانبية غير المذكورة في النشرة، يرجى إخبار الطبيب أو الصيدلي.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ بعيدا عن متناول أيدي ونظر الأطفال .</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا يحفظ في درجة حرارة أعلى من 30 درجة مئوية.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;يحفظ في العبوة الأصلية للحماية من الضوء والرطوبة.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدم الترازول&nbsp; بعد تاريخ انتهاء الصلاحية المدون على العبوة وعلى الكرتون. تاريخ انتهاء الصلاحية يشير إلى اليوم الأخير من هذا الشهر .</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تتخلص من أي أدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد مطلوبة. هذه التدابير تساعد في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>تحتوي كل كبسولة على لانسوبرازول&nbsp; 30ملجم.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            كبسولات ألترازول 30 ملجم : جسم أصفر معتم ورأس أزرق معتم مع طباعة RP 9 باللون الأبيض على الرأس، و تحتوي كريات معوية مغلفة ملونة باللون الأبيض الى الأبيض الداكن.
كبسولات ألترازول 30 ملجم : 14 كبسولة في عبوة بيضاء من البولي ايثيلين عالي الكثافة مع غطاء بلاستيكي آمن للأطفال و مجفف.
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>شركة المنتجات الطبية والتجميلية المحدودة (الرياض فارما)</p><p>ص.ب. 442 الرياض 11411</p><p>فاكس: 966112650505+</p><p>contact@riyadhpharma.comالبريد الإلكتروني:</p><p><em>لأية معلومات عن هذا المنتج الطبي، يرجى الاتصال على صاحب الترخيص والتسويق:</em></p><p>المملكة العربية السعودية</p><p>قسم التسويق</p><p>الرياض</p><p>تلفون: 966112650111+</p><p>marketing@riyadhpharma.comالبريد الإلكتروني:</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            5/2017
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                ULTRAZOLE 30mg CAPSULE
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Ultrazole Capsules 15 mg: Each capsule contains 15 mg of Lansoprazole.
Ultrazole Capsules 30 mg: Each capsule contains 30 mg of Lansoprazole.
For a full list of excipients, see section 6.1
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Ultrazole Capsules 15 mg: capsules having light green opaque body and opaque green head with printing RP 28 on head containing white to off-white spherical enteric coated pellets.
Ultrazole Capsules 30 mg: capsules having yellow opaque body and blue opaque head with printing RP 9 in white ink on head containing white to off-white spherical enteric coated pellets.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <ul><li>Treatment of duodenal and gastric ulcer</li><li>Treatment of reflux oesophagitis</li><li>Prophylaxis of reflux oesophagitis</li><li>Eradication of Helicobacter pylori (H. pylori) concurrently given with appropriate antibiotic therapy for treatment of H.pylori-associated ulcer.</li><li>Treatment of NSAID-associated benign gastric and duodenal ulcers in patients requiring continued NSAID treatment</li><li>Prophylaxis of NSAID-associated gastric ulcers and duodenal ulcers in patients at risk (see section 4.2) requiring continued therapy</li><li>Symptomatic gastroesophageal reflux disease</li><li>Zollinger-Ellison syndrome.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Posology</strong></p><p><strong>Treatment of duodenal ulcer:</strong><br />The recommended dose is 30 mg once daily for 2 weeks. In patients not fully healed within this time, the medication is continued at the same dose for another two weeks.</p><p><strong>Treatment of gastric ulcer:</strong><br />The recommended dose is 30 mg once daily for 4 weeks. The ulcer usually heals within 4 weeks, but in patients not fully healed within this time, the medication may be continued at the same dose for another 4 weeks.</p><p><strong>Reflux oesophagitis:</strong><br />The recommended dose is 30 mg once daily for 4 weeks. In patients not fully healed within this time, the treatment may be continued at the same dose for another 4 weeks.</p><p><strong>Prophylaxis of reflux oesophagitis:</strong><br />15 mg once daily. The dose may be increased up to 30 mg daily as necessary.</p><p><strong>Eradication of Helicobacter pylori:</strong><br />When selecting appropriate combination therapy consideration should be given to official local guidance regarding bacterial resistance, duration of treatment, (most commonly 7 days but sometimes up to 14 days), and appropriate use of antibacterial agents.<br />The recommended dose is 30 mg of lansoprazole twice daily for 7 days in combination with one of the following:<br />clarithromycin 250-500 mg twice daily + amoxicillin 1 g twice daily<br />clarithromycin 250 mg twice daily + metronidazole 400-500 mg twice daily<br />H. pylori eradication rates of up to 90%, are obtained when clarithromycin is combined with lansoprazole and amoxicillin or metronidazole.<br />Six months after successful eradication treatment, the risk of re-infection is low and relapse is therefore<br />unlikely.<br />Use of a regimen including lansoprazole 30 mg twice daily, amoxicillin 1 g twice daily and metronidazole 400-500 mg twice daily has also been examined. Lower eradication rates were seen using this combination than in regimens involving clarithromycin. It may be suitable for those who are unable to take clarithromycin as part of an eradication therapy, when local resistance rates to metronidazole are low.</p><p><strong>Treatment of NSAID associated benign gastric and duodenal ulcers in patients requiring continued NSAID treatment:</strong><br />30 mg once daily for four weeks. In patients not fully healed the treatment may be continued for another four weeks. For patients at risk or with ulcers that are difficult to heal, a longer course of treatment and/or a higher dose should probably be used.</p><p><strong>Prophylaxis of NSAID associated gastric and duodenal ulcers in patients at risk (such as age &gt; 65 or history of gastric or duodenal ulcer) requiring prolonged NSAID treatment:</strong><br />15 mg once daily. If the treatment fails the dose 30 mg once daily should be used.</p><p><strong>Symptomatic gastro-oesophageal reflux disease:</strong><br />The recommended dose is 15 mg or 30 mg daily. Relief of symptoms is obtained rapidly. Individual adjustment of dosage should be considered. If the symptoms are not relieved within 4 weeks with a daily dose of 30 mg, further examinations are recommended.</p><p><strong>Zollinger-Ellison syndrome:</strong><br />The recommended initial dose is 60 mg once daily. The dose should be individually adjusted and the treatment should be continued for as long as necessary. Daily doses of up to 180 mg have been used. If the required daily dose exceeds 120 mg, it should be given in two divided doses.</p><p><strong>Impaired hepatic or renal function:</strong><br />There is no need for a dose adjustment in patients with impaired renal function.<br />Patients with moderate or severe liver disease should be kept under regular supervision and a 50% reduction of the daily dose is recommended (see section 4.4 and 5.2).</p><p><strong>Elderly:</strong><br />Due to reduced clearance of lansoprazole in the elderly an adjustment of dose may be necessary based on individual requirements. A daily dose of 30 mg should not be exceeded in the elderly unless there are compelling clinical indications.</p><p><strong>Paediatric population:</strong><br />The use of Lansoproazole is not recommended in children as clinical data are limited (see also section 5.2).<br />Treatment of small children below one year of age should be avoided as available data have not shown beneficial effects in the treatment of gastro-oesophageal reflux disease.</p><p><strong>Method of administration</strong><br />For optimal effect, lansoprazole should be taken once daily in the morning, except when used for H. pylori eradication when treatment should be twice a day, once in the morning and once in the evening. Lansoprazole should be taken at least 30 minutes before food (see section 5.2). Capsules should be swallowed whole with liquid.<br />For patients with difficulty swallowing; studies and clinical practice suggest that the capsules may be opened and the granules mixed with a small amount of water, apple/tomato juice or sprinkled onto a small amount of soft food (e.g. yoghurt, apple puree) to ease administration. Capsules may also be opened and granules mixed with 40 ml of apple juice for administration through a nasogastric tube (see section 5.2). After preparing the<br />suspension or mixture, the drug should be administered immediately.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Lansoprazole should not be administered with atazanavir (see section 4.5).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In common with other anti-ulcer therapies, the possibility of malignant gastric tumour should be excluded when treating a gastric ulcer with lansoprazole because lansoprazole can mask the symptoms and delay the diagnosis.<br />Lansoprazole should be used with caution in patients with moderate and severe hepatic dysfunction (see sections 4.2 and 5.2).<br />Decreased gastric acidity due to lansoprazole might be expected to increase gastric counts of bacteria normally present in the gastrointestinal tract. Treatment with lansoprazole may lead to a slightly increased risk of gastrointestinal infections such as Salmonella and Campylobacter. In patients suffering from gastro-duodenal ulcers, the possibility of H. pylori infection as an etiological factor should be considered.<br />If lansoprazole is used in combination with antibiotics for eradication therapy of H.pylori, then the instructions for the use of these antibiotics should also be followed.<br />Because of limited safety data for patients on maintenance treatment for longer than 1 year, regular review of the treatment and a thorough risk/benefit assessment should regularly be performed in these patients. Very rarely cases of colitis have been reported in patients taking lansoprazole. Therefore, in the case of severe and/or persistent diarrhoea, discontinuation of therapy should be considered.<br />The treatment for the prevention of peptic ulceration of patients in need of continuous NSAID treatment should be restricted to high risk patients (e.g. previous gastrointestinal bleeding, perforation or ulcer, advanced age, concomitant use of medication known to increase the likelihood of upper GI adverse events [e.g. corticosteroids or anticoagulants], the presence of a serious co-morbidity factor or the prolonged use of NSAID maximum recommended doses).<br />Severe hypomagnesaemia has been reported in patients treated with PPIs like lansoprazole for at least three months, and in most cases for a year. Serious manifestations of hypomagnesaemia such as fatigue, tetany, delirium, convulsions, dizziness and ventricular arrhythmia can occur but they may begin insidiously and be overlooked. In most affected patients, hypomagnesaemia improved after magnesium replacement and discontinuation of the PPI.<br />For patients expected to be on prolonged treatment or who take PPIs with digoxin or drugs that may cause hypomagnesaemia (e.g., diuretics), health care professionals should consider measuring magnesium levels before starting PPI treatment and periodically during treatment.<br />Proton pump inhibitors, especially if used in high doses and over long durations (&gt;1 year), may modestly increase the risk of hip, wrist and spine fracture, predominantly in the elderly or in presence of other recognised risk factors. Observational studies suggest that proton pump inhibitors may increase the overall risk of fracture by 10&ndash;40%. Some of this increase may be due to other risk factors. Patients at risk of osteoporosis should receive care according to current clinical guidelines and they should have an adequate intake of vitamin D and calcium.</p><p><strong>Subacute cutaneous lupus erythematosus (SCLE)</strong><br />Proton pump inhibitors are associated with very infrequent cases of SCLE. If lesions occur, especially in sun-exposed areas of the skin, and if accompanied by arthralgia, the patient should seek medical help promptly and the health care professional should consider stopping Lansoprazole 15 mg Gastro-Resistant Capsules. SCLE after previous treatment with a proton pump inhibitor may increase the risk of SCLE with other proton pump inhibitors.</p><p><strong>Interference with laboratory tests</strong><br />Increased Chromogranin A (CgA) level may interfere with investigations for neuroendocrine tumours. To avoid this interference, Lansoprazole 15 mg Gastro-Resistant Capsules treatment should be stopped for at least 5 days before CgA measurements (see section 5.1). If CgA and gastrin levels have not returned to reference range after initial measurement, measurements should be repeated 14 days after cessation of proton pump inhibitor treatment.<br />As lansoprazole contains sucrose, patients with rare hereditary problems of fructose intolerance, glucosegalactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Effects of lansoprazole on other drugs<br />Medicinal products with pH dependent absorption</strong><br />Lansoprazole may interfere with the absorption of drugs where gastric pH is critical to bioavailability.</p><p><em><strong>Atazanavir:</strong></em><br />A study has shown that co-administration of lansoprazole (60 mg once daily) with atazanavir 400 mg to healthy volunteers resulted in a substantial reduction in atazanavir exposure (approximately 90% decrease in AUC and Cmax). Lansoprazole should not be co-administered with atazanavir (see section 4.3).</p><p><em><strong>Ketoconazole and itraconazole:</strong></em><br />The absorption of ketoconazole and itraconazole from the gastrointestinal tract is enhanced by the presence of gastric acid. Administration of lansoprazole may result in sub-therapeutic concentrations of ketoconazole and itraconazole and the combination should be avoided.</p><p><em><strong>Digoxin:</strong></em><br />Co-administration of lansoprazole and digoxin may lead to increased digoxin plasma levels. The plasma levels of digoxin should therefore be monitored and the dose of digoxin adjusted if necessary when initiating and ending lansoprazole treatment.</p><p><strong>Medicinal products metabolised by P450 enzymes</strong><br />Lansoprazole may increase plasma concentrations of drugs that are metabolised by CYP3A4. Caution is advised when combining lansoprazole with drugs which are metabolised by this enzyme and have a narrow therapeutic window.</p><p><strong><em>Theophylline:</em></strong><br />Lansoprazole reduces the plasma concentration of theophylline, which may decrease the expected clinical&nbsp; effect at the dose. Caution is advised when combining the two drugs.</p><p><strong><em>Tacrolimus:</em></strong><br />Co-administration of lansoprazole increases the plasma concentrations of tacrolimus (a CYP3A and Pgp substrate). Lansoprazole exposure increased the mean exposure of tacrolimus by up to 81%.<br />Monitoring of tacrolimus plasma concentrations is advised when concomitant treatment with lanzoprazole is initiated or ended.</p><p><strong>Medicinal products transported by P-glycoprotein</strong><br />Lansoprazole has been observed to inhibit the transport protein, P-glycoprotein (P-gp) in vitro. The clinical relevance of this is unknown.</p><p><strong>Effects of other drugs on lansoprazole</strong></p><p><strong>Drugs which inhibit CYP2C19</strong><br /><strong><em>Fluvoxamine:</em></strong><br />A dose reduction may be considered when combining lansoprazole with the CYP2C19 inhibitor fluvoxamine. The plasma concentrations of lansoprazole increase up to 4-fold.<br /><strong><em>Drugs which induces CYP2C19 and CYP3A4</em></strong><br />Enzyme inducers affecting CYP2C19 and CYP3A4 such as rifampicin, and St John&acute;s wort (Hypericum perforatum) can markedly reduce the plasma concentrations of lansoprazole.</p><p><strong>Others</strong><br /><strong><em>Sucralfate/Antacids:</em></strong><br />Sucralfate/Antacids may decrease the bioavailability of lansoprazole. Therefore lansoprazole should be taken at least 1 hour after taking these drugs.<br />No clinically significant interactions of lansoprazole with nonsteroidal anti-inflammatory drugs have been demonstrated, although no formal interactions studies have been performed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy:</strong><br />For lansoprazole no clinical data on exposed pregnancies are available. Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development.<br />Therefore, the use of lansoprazole during pregnancy is not recommended.</p><p><strong>Breastfeeding:</strong><br />It is not known whether lansoprazole is excreted in human breast milk. Animal studies have shown excretion of lansoprazole in milk.<br />A decision on whether to continue/discontinue breast-feeding or to continue/discontinue therapy with lansoprazole should be made taking into account the benefit of breastfeeding to the child and the benefit of lansoprazole therapy to the woman.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse drug reactions such as dizziness, vertigo, visual disturbances and somnolence may occur (see section 4.8). Under these conditions the ability to react may be decreased.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Frequencies are defined as common (&ge; 1/100 to &lt; 1/10); uncommon (&ge; 1/1,000 to &lt; 1/100); rare (&ge;1/10,000 to &lt;1/1,000); very rare (&lt;1/10,000), not known (cannot be estimated from the available data).</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p><strong>Common</strong></p></td><td style="vertical-align:top"><p><strong>Uncommon</strong></p></td><td style="vertical-align:top"><p><strong>Rare</strong></p></td><td style="vertical-align:top"><p><strong>Very rare</strong></p></td><td style="vertical-align:top"><p><strong>Not known</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Blood and lymphatic system disorders</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Thrombocytopenia,eosinophi lia, leucopenia</p></td><td style="vertical-align:top"><p>Anaemia</p></td><td style="vertical-align:top"><p>Agranulocytosi s, pancytopenia</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Metabolism and nutritional disorders</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Hypomagnesaemia<em>s</em><em> ee section4.4</em></p></td></tr><tr><td style="vertical-align:top"><p><strong>Psychiatric Disorders</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Depression</p></td><td style="vertical-align:top"><p>Insomnia, hallucination, confusion</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Nervous system Disorders</strong></p></td><td style="vertical-align:top"><p>Headache, dizziness</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Restlessness, vertigo, paresthesia, somnolence, tremor</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr></tbody></table><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Eye disorders</strong></p></td><td style="vertical-align:top; width:192px"><p>&nbsp;</p></td><td style="vertical-align:top; width:150px"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Visual disturbances.</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Gastrointestin al Disorders</strong></p></td><td style="vertical-align:top; width:192px"><p>Nausea, diarrhoea, stomach ache, constipatio n, vomiting, flatulence, dry mouth or throat</p></td><td style="vertical-align:top; width:150px"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Glossitis, candidiasis of the oesophagus, pancreatitis, taste disturbances</p></td><td style="vertical-align:top"><p>Colitis, stomatitis</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Hepatobiliary disorders</strong></p></td><td style="vertical-align:top; width:192px"><p>Increase in liver enzyme levels</p></td><td style="vertical-align:top; width:150px"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Hepatitis, jaundice</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Skin and subcutaneous tissue disorders</strong></p></td><td style="vertical-align:top; width:192px"><p>Urticaria, itching, rash</p></td><td style="vertical-align:top; width:150px"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Petechiae, purpura, hair loss, erythema multiforme, photosensitivit y</p></td><td style="vertical-align:top"><p>Steven- Johnson syndrome, toxic epidermal necrolysis</p></td><td style="vertical-align:top"><p>Subacute cutaneous lupus erythematosus (see section 4.4)</p></td></tr><tr><td style="vertical-align:top"><p><strong>Musculoskelet al and connective tissue disorders</strong></p></td><td style="vertical-align:top; width:192px"><p>&nbsp;</p></td><td style="vertical-align:top; width:150px"><p>Arthralgia, myalgia Fracture of the hip, wrist or spine (see section 4.4)</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Renal and urinary disorders</strong></p></td><td style="vertical-align:top; width:192px"><p>&nbsp;</p></td><td style="vertical-align:top; width:150px"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Interstitial nephritis</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Reproductive system and breast disorders</strong></p></td><td style="vertical-align:top; width:192px"><p>&nbsp;</p></td><td style="vertical-align:top; width:150px"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Gynaecomasti a</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>General disorders and administration site conditions</strong></p></td><td style="vertical-align:top; width:192px"><p>Fatigue</p></td><td style="vertical-align:top; width:150px"><p>Oedema</p></td><td style="vertical-align:top"><p>Fever, hyperhidrosis, angioedema, anorexia, impotence</p></td><td style="vertical-align:top"><p>Anaphylactic shock</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Investigations</strong></p></td><td style="vertical-align:top; width:192px"><p>&nbsp;</p></td><td style="vertical-align:top; width:150px"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Increase in cholesterol and triglyceride levels, hyponatremia</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr></tbody></table><p><strong>To report any side effects</strong></p><p>-&nbsp;&nbsp; National Pharmacovigilance and Drug Safety Center (NPC)</p><p>o Fax: +966-11-205-7662</p><p>o&nbsp; To call the executive management of vigilance and crisis management: +966-11-2038222 ext.: 2353 &ndash; 2356 &ndash; 2317 &ndash; 2354 &ndash; 2334 &ndash; 2340</p><p>o Toll-free: 8002490000</p><p>o&nbsp; E-mail: <u>npc.drug@sfda.gov.sa</u></p><p>o&nbsp; Website: <u>www.sfda.gov.sa/npc</u></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The effects of overdose on lansoprazole in humans are not known (although the acute toxicity is likely to be low) and, consequently, instruction for treatment cannot be given. However, daily doses of up to 180 mg of lansoprazole orally and up to 90 mg of lansoprazole intravenously have been administered in trials without significant undesirable effects.<br />Please refer to section 4.8 for possible symptoms of lansoprazole overdose.<br />In the case of suspected overdose the patient should be monitored. Lansoprazole is not significantly eliminated by haemodialysis. If necessary, gastric emptying, charcoal and symptomatic therapy is recommended.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Proton pump inhibitors, ATC code: A02BC03<br />Lansoprazole is a gastric proton pump inhibitor. It inhibits the final stage of gastric acid formation by inhibiting the activity of H+/K+ ATPase of the parietal cells in the stomach. The inhibition is dosedependent and reversible, and the effect applies to both basal and stimulated secretion of gastric acid. Lansoprazole is concentrated in the parietal cells and becomes active in their acidic environment, whereupon it reacts with the sulphydryl group of H+/K+ATPase causing inhibition of the enzyme activity.</p><p><strong>Effect on gastric acid secretion:</strong><br />Lansoprazole is a specific inhibitor of the parietal cell proton pump. A single oral dose of Lansoprazole inhibits pentagastrin-stimulated gastric acid secretion by about 80%. After repeated daily administration for seven days, about 90% inhibition of gastric acid secretion is achieved. It has a corresponding effect on the basal secretion of gastric acid. A single oral dose of 30 mg reduces basal secretion by about 70%, and the patients&#39; symptoms are consequently relieved starting from the very first dose. After eight days of repeated administration the reduction is about 85%. A rapid relief of symptoms is obtained by one capsule (30 mg) daily, and most patients with duodenal ulcer recover within 2 weeks, patients with gastric ulcer and reflux oesophagitis within 4 weeks. By reducing gastric acidity, lansoprazole creates an environment in which appropriate antibiotics can be effective against H. pylori.<br />During treatment with antisecretory medicinal products, serum gastrin increases in response to the decreased acid secretion. Also CgA increases due to decreased gastric acidity. The increased CgA level may interfere with investigations for neuroendocrine tumours.<br />Available published evidence suggests that proton pump inhibitors should be discontinued between 5 days and 2 weeks prior to CgA measurements. This is to allow CgA levels that might be spuriously elevated following PPI treatment to return to reference range.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Lansoprazole is a racemate of two active enantiomers that are biotransformed into the active form in the acidic environment of the parietal cells. As lansoprazole is rapidly inactivated by gastric acid, it is administered orally in enteric-coated form(s) for systemic absorption.</p><p><strong>Absorption and distribution</strong><br />Lansoprazole exhibits high (80-90%) bioavailability with a single dose. Peak plasma levels occur within 1.5 to 2.0 hours. Intake of food slows the absorption rate of lansoprazole and reduces the bioavailabilty by about 50%. The plasma protein binding is 97%.<br />Studies have shown that granules from opened capsules give equivalent AUC as the intact capsule if the granules are suspended in a small amount of orange juice, apple juice, or tomato juice mixed with a tablespoon of apple or pear puree or sprinkled on a tablespoon of yoghurt, pudding or cottage cheese. Equivalent AUC has also been shown for granules suspended in apple juice administered through a nasogastric tube.</p><p><strong>Biotransformation and elimination</strong><br />Lansoprazole is extensively metabolised by the liver and the metabolites are excreted by both the renal and biliary route. The metabolism of lansoprazole is mainly catalysed by the enzyme CYP2C19. The enzyme CYP3A4 also contributes to the metabolism. The plasma elimination half-life ranges from 1 to 2 hours following single or multiple doses in healthy subjects. There is no evidence of accumulation following multiple doses in healthy subjects. Sulphone, sulphide and 5-hydroxyl derivatives of lansoprazole have been identified in plasma. These metabolites have very little or no antisecretory activity.<br />A study with 14C labelled lansoprazole indicated that approximately one-third of the administered radiation was excreted in the urine and two-thirds was recovered in the faeces.</p><p><strong>Pharmacokinetics in elderly patients</strong><br />The clearance of lansoprazole is decreased in the elderly, with elimination half-life increased approximately 50% to 100%. Peak plasma levels were not increased in the elderly.</p><p><strong>Pharmacokinetics in paediatric patients</strong><br />The evaluation of the pharmacokinetics in children aged 1 &ndash;17 years of age showed a similar exposure as compared to adults with doses of 15 mg for those below 30 kg of weight and 30 mg for those above. The investigation of a dose of 17 mg/m2 body surface or 1 mg/kg body weight also resulted in comparable exposure of lansoprazole in children aged 2-3 months up to one year of age compared to adults.<br />Higher exposure to lansoprazole in comparison to adults has been seen in infants below the age of 2-3 months with doses of both 1.0 mg/kg and 0.5 mg/kg body weight given as a single dose.</p><p><strong>Pharmacokinetics in hepatic insufficiency</strong><br />The exposure of lansoprazole is doubled in patients with mild hepatic impairment and much more increased in patients with moderate and severe hepatic impairment.</p><p><strong>CYP2C19 poor metabolisers</strong><br />CYP2C19 is subject to genetic polymorphism and 2-6 % of the population, called poor metabolisers (PMs), are homozygote for a mutant CYP2C19 allele and therefore lacks a functional CYP2C19 enzyme. The exposure of lansoprazole is several-fold higher in PMs than in extensive metabolisers (EMs)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data reveal no special hazards for humans based on conventional studies of safety pharmacology, repeated dose toxicity, toxicity to reproduction or genotoxicity.<br />In two rat carcinogenicity studies, lansoprazole produced dose-related gastric ECL cell hyperplasia and ECL cell carcinoids associated with hypergastrinaemia due to inhibition of acid secretion.<br />Intestinal metaplasia was also observed, as were Leydig cell hyperplasia and benign Leydig cell tumours.<br />After 18 months of treatment retinal atrophy was observed. This was not seen in monkeys, dogs or mice.<br />In mouse carcinogenicity studies dose-related gastric ECL cell hyperplasia developed as well as liver tumours and adenoma of rete testis.<br />The clinical relevance of these findings is unknown.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>1. Lansoprazole 8.5% pellets (eq. to 15 mg Lansoprazole) Capsule Shell (size 1) RP 28<br />2. Lansoprazole 8.5% pellets (eq. to 30 mg Lansoprazole) Capsule Shell (size 2) RP 09</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Keep out of the reach &amp; sight of children.<br />Store below 30&deg;C.<br />Store in the original package, in order to protect from light and moisture.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Ultrazole Capsules 15 mg Container: </strong>White high density polyethelene bottle with child resistance plastic cap with desiccant contains 28 capsules (having light green opaque body and opaque green head with printing RP 28 on head containing white to off-white spherical enteric coated pellets.</p><p><br /><strong>Ultrazole Capsules 30 mg Container:</strong> White high density polyethelene bottle with child resistance plastic cap with desiccant contains 14 capsules (having yellow opaque body and blue opaque head with printing RP 9 in white ink on head containing white to off-white spherical enteric coated pellets.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Medical and Cosmetic Products Company Ltd. (Riyadh Pharma)
P.O. Box 442, Riyadh 11411
Fax: +966 11 265 0505
Email: contact@riyadhpharma.com
For any information about this medicinal product, please contact the local representative of marketing authorization holder:
Saudi Arabia
Marketing department
Riyadh
Tel: +966 11 265 0111
Email: marketing@riyadhpharma.com
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                16/05/2017
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>